STANDARD BIOTOOLS INC (LAB)
US34385P1084 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 130.6M -5.43% | 97.9M -25.04% | 106.34M 8.62% | 172.91M 62.60% | 188.8M 9.19% | 226.45M 19.94% | 255.23M 12.71% | |
| EBITDA YoY % growth | -51.93M -48.03% | -101.17M -94.82% | -47.859M 52.69% | -86.759M -81.28% | -69.791M 19.56% | -2.02M 97.11% | 68.983M 3,515.00% | |
| EBIT YoY % growth | -67.5M -32.35% | -116.2M -72.15% | -63.039M 45.75% | -174.276M -176.46% | -89.739M 48.51% | -39.289M 56.22% | -15.655M 60.15% | |
| Operating Margin | -51.68% | -118.69% | -59.28% | -100.79% | -47.53% | -17.35% | -6.13% | |
| EPS YoY % growth | -0.78 -6.85% | N/A | -0.85 | -0.53 38.21% | -0.22 57.69% | -0.09 59.09% | -0.02 77.78% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 71.72% | -0.07 73.81% | -0.05 57.92% | -0.04 42.29% | -0.02 71.43% |
| Revenue Q2Q % growth | 43.464M 54.19% | 46.056M 1.13% | 42.319M 13.75% | 49.137M 9.27% | 49.036M 12.82% |
| EBITDA Q2Q % growth | -17.423M -6,458.58% | -18.483M 44.89% | -15.15M 54.00% | -19.392M -70.25% | -17.978M -3.19% |
| EBIT Q2Q % growth | -30.755M -106.32% | -27.876M 28.03% | -20.2M 51.89% | -13.635M 43.88% | -7.979M 74.06% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.07 74.07% | -0.09 | 0.02 | 22.99% |
| Q2 2024 Q2Q % growth | -0.12 45.45% | -0.09 | -0.03 | -39.78% |
| Q1 2024 Q2Q % growth | -0.27 -145.45% | -0.11 | -0.16 | -135.88% |
| Q4 2023 Q2Q % growth | -0.25 -31.58% | -0.13 | -0.12 | -90.40% |
| Q3 2023 Q2Q % growth | -0.27 -3.85% | -0.12 | -0.15 | -122.77% |
| Q2 2023 Q2Q % growth | -0.22 33.33% | -0.21 | -0.01 | -3.72% |
| Q1 2023 Q2Q % growth | -0.11 56.00% | % | ||
| Q4 2022 Q2Q % growth | -0.19 -58.33% | % | ||
| Q3 2022 Q2Q % growth | -0.26 -44.44% | % | ||
| Q2 2022 Q2Q % growth | -0.33 -43.48% | % | ||
| Q1 2022 Q2Q % growth | -0.25 | % | ||
| Q4 2021 Q2Q % growth | -0.12 50.00% | -0.28 | 0.16 | 57.57% |
| Q3 2021 Q2Q % growth | -0.18 -125.00% | -0.22 | 0.04 | 18.99% |
| Q2 2021 Q2Q % growth | -0.23 -27.78% | -0.20 | -0.03 | -16.78% |
| Q1 2021 Q2Q % growth | -0.25 -8.70% | -0.14 | -0.11 | -72.70% |
| Q4 2020 Q2Q % growth | -0.24 -33.33% | -0.07 | -0.17 | -256.42% |
| Q3 2020 Q2Q % growth | -0.08 57.89% | -0.20 | 0.12 | 60.40% |
| Q2 2020 Q2Q % growth | -0.18 10.00% | -0.23 | 0.05 | 22.51% |
| Q1 2020 Q2Q % growth | -0.23 17.86% | -0.15 | -0.08 | -51.82% |
| Q4 2019 Q2Q % growth | -0.18 | -0.19 | 0.01 | 5.20% |
| Q3 2019 Q2Q % growth | -0.19 | -0.20 | 0.01 | 6.87% |
| Q2 2019 Q2Q % growth | -0.20 | -0.21 | 0.01 | 4.80% |
| Q1 2019 Q2Q % growth | -0.28 | -0.25 | -0.03 | -10.01% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 44.969M 77.27% | 41.408M | 3.561M | 8.60% |
| Q2 2024 Q2Q % growth | 37.205M 35.36% | 48.733M | -11.528M | -23.66% |
| Q1 2024 Q2Q % growth | 45.54M 81.29% | 46.466M | -926K | -1.99% |
| Q4 2023 Q2Q % growth | 28.188M 4.32% | 25.149M | 3.039M | 12.08% |
| Q3 2023 Q2Q % growth | 25.367M -1.10% | 23.836M | 1.531M | 6.42% |
| Q2 2023 Q2Q % growth | 27.486M 46.36% | 24.442M | 3.044M | 12.45% |
| Q1 2023 Q2Q % growth | 25.12M -5.21% | % | ||
| Q4 2022 Q2Q % growth | 27.02M -29.40% | % | ||
| Q3 2022 Q2Q % growth | 25.65M -10.00% | % | ||
| Q2 2022 Q2Q % growth | 18.78M -39.46% | % | ||
| Q1 2022 Q2Q % growth | 26.5M -19.18% | % | ||
| Q4 2021 Q2Q % growth | 38.27M -14.21% | 33.027M | 5.243M | 15.87% |
| Q3 2021 Q2Q % growth | 28.5M -28.50% | 30.3M | -1.8M | -5.94% |
| Q2 2021 Q2Q % growth | 31.02M 19.03% | 31.326M | -306K | -0.98% |
| Q1 2021 Q2Q % growth | 32.79M 18.72% | 32.291M | 499K | 1.55% |
| Q4 2020 Q2Q % growth | 44.61M 37.52% | 51.227M | -6.617M | -12.92% |
| Q3 2020 Q2Q % growth | 39.86M 50.42% | 32.783M | 7.077M | 21.59% |
| Q2 2020 Q2Q % growth | 26.06M -7.59% | 19.261M | 6.799M | 35.30% |
| Q1 2020 Q2Q % growth | 27.62M -8.27% | 29.32M | -1.7M | -5.80% |
| Q4 2019 Q2Q % growth | 32.44M | 31.148M | 1.292M | 4.15% |
| Q3 2019 Q2Q % growth | 26.5M | 29.023M | -2.523M | -8.69% |
| Q2 2019 Q2Q % growth | 28.2M | 30.363M | -2.163M | -7.12% |
| Q1 2019 Q2Q % growth | 30.11M | 29.488M | 622K | 2.11% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -27.27% | 0% | -13.04% |
| Revenue | 0% | -22.2% | 0% | -0.17% |